A bill to ensure that rules for the approval of pharmaceutical and biological products do not require violations of medical ethics in the testing of products in humans and vertebrate animals.
The bill’s titles are written by its sponsor.
Sep 29, 2010
111th Congress, 2009–2010
Died in a previous Congress
This bill was introduced on September 29, 2010, in a previous session of Congress, but was not enacted.
Senator from Vermont
Read Text »
Last Updated: Sep 29, 2010
Length: 10 pages
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 3506 (112th).
S. 3921 (111th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 111th Congress, which met from Jan 6, 2009 to Dec 22, 2010. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2017). S. 3921 — 111th Congress: Ethical Pathway Act of 2010. Retrieved from https://www.govtrack.us/congress/bills/111/s3921
“S. 3921 — 111th Congress: Ethical Pathway Act of 2010.” www.GovTrack.us. 2010. June 25, 2017 <https://www.govtrack.us/congress/bills/111/s3921>
|title=S. 3921 (111th)
|accessdate=June 25, 2017
|author=111th Congress (2010)
|date=September 29, 2010
|quote=Ethical Pathway Act of 2010
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.